Zobrazeno 1 - 10
of 10
pro vyhledávání: '"P E, Lovat"'
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0265048 (2022)
ObjectivesCutaneous melanoma rates are steadily increasing. Up to 20% of patients diagnosed with AJCC Stage I/II melanomas will develop metastatic disease. To date there are no consistently reliable means to accurately identify truly high versus low-
Externí odkaz:
https://doaj.org/article/b066aa54756a40b0a9efe11e4085744b
Autor:
Dow-Mu Koh, Sue Creviston Kaste, Sarah J. Vinnicombe, Giovanni Morana, Andrea Rossi, Christian J. Herold, Theresa C. McLoud, Kirk A. Frey, Bernhard Gebauer, Derek Roebuck, Jurgen J. Fütterer, Alexander J. Towbin, Thierry A. G. Huisman, Anne M. J. B. Smets, Jeong Min Lee, Hersh Chandarana, Marius E. Mayerhoefer, Markus Raderer, Alexander Haug, Matthias Eiber, Andrea Rockall, Aslam Sohaib, Victoria S Warbey, Hebert Alberto Vargas, Jay P. Heiken, Isaac R. Francis, Mahmoud M. Al-Hawary, Ravi K. Kaza, Mirko D’Onofrio, Harriet C. Thoeny, Ann D. King, Arnoldo Piccardo, Maria Luisa Garrè, Nick Reed, Carlos Rodriguez-Galindo, Ashish P. Wasnik, Stefan Diederich, Wim J. G. Oyen, Cheng Lee Chaw, Nicholas van As, Igor Vieira, Frederik De Keyzer, Elleke Dresen, Sileny Han, Ignace Vergote, Philippe Moerman, Frederic Amant, Michel Koole, Vincent Vandecaveye, R. Dresen, S. De Vuysere, F. De Keyzer, E. Van Cutsem, A. D’Hoore, A. Wolthuis, V. Vandecaveye, P. Pricolo, S. Alessi, P. Summers, E. Tagliabue, G. Petralia, C. Pfannenberg, B. Gückel, S. C. Schüle, A. C. Müller, S. Kaufmann, N. Schwenzer, M. Reimold, C. la Fougere, K. Nikolaou, P. Martus, G. J. Cook, G. K. Azad, B. P. Taylor, M. Siddique, J. John, J. Mansi, M. Harries, V. Goh, S. Seth, R. Burgul, A. Seth, S. Waugh, N. Muhammad Gowdh, C. Purdie, A. Evans, E. Crowe, A. Thompson, S. Vinnicombe, F. Arfeen, T. Campion, E. Goldstraw, M. D’Onofrio, V. Ciaravino, S. Crosara, R. De Robertis, R. Pozzi Mucelli, M. Uhrig, D. Simons, H. Schlemmer, Kate Downey, S. Murdoch, A. S. Al-adhami, S. Viswanathan, S. Smith, P. Jennings, D. Bowers, R. Soomal, T. M. Mutala, A. O. Odhiambo, N. Harish, M. Hall, M. Sproule, S. Sheridan, K. Y. Thein, C. H. Tan, Y. L. Thian, C. M. Ho, S. De Luca, C. Carrera, V. Blanchet, L. Alarcón, E. Eyheremnedy, B. K. Choudhury, K. Bujarbarua, G. Barman, E. Lovat, R. Ferner, V. S. Warbey, L. Potti, B. Kaye, A. Beattie, K. Dutton, A. A. Seth, F. Constantinidis, H. Dobson, R. Bradley, G. Bozas, G. Avery, A. Stephens, A. Maraveyas, S. Bhuva, C. A. Johnson, M. Subesinghe, N. Taylor, L. E. Quint, R. M. Reddy, G. P. Kalemkerian, G. González Zapico, E. Gainza Jauregui, R. Álvarez Francisco, S. Ibáñez Alonso, I. Tavera Bahillo, L. Múgica Álvarez, O. Francies, R. Wheeler, L. Childs, A. Adams, A. Sahdev, S. E. De Luca, M. E. Casalini Vañek, M. D. Pascuzzi, T. Gillanders, P. M. Ramos, E. P. Eyheremendy, C. Stove, M. Digby, M. Nazar, M. Wirtz, F. Troncoso, F. Saguier, D. J. Quint, L. Dang, M. Carlson, S. Leber, F. Silverstein, R. Rueben, B. Nazir, T. H. Teo, J. B. Khoo, K. Sharma, N. Gupta, B. Mathew, T. Jeyakumar, K. Harkins, S. Joshua, D. Christodoulou, S. Gourtsoyianni, A. Jacques, N. Griffin, J. Lee, J. A. Goodfellow, A. Yong, S. Jenkins, G. Joseph, K. Partington, A. Zanfardini, K. Cavanagh, E. Lau
Publikováno v:
Cancer Imaging, Vol 16, Iss S1, Pp 1-34 (2016)
Table of contents O1 Tumour heterogeneity: what does it mean? Dow-Mu Koh O2 Skeletal sequelae in adult survivors of childhood cancer Sue Creviston Kaste O3 Locoregional effects of breast cancer treatment Sarah J Vinnicombe O4 Imaging of cancer therap
Externí odkaz:
https://doaj.org/article/bbc9ed6b29934836b9bbcd92740a4db6
Autor:
John D. Widdrington, Aurora Gomez-Duran, Angela Pyle, Marie-Helene Ruchaud-Sparagano, Jonathan Scott, Simon V. Baudouin, Anthony J. Rostron, Penny E. Lovat, Patrick F. Chinnery, A. John Simpson
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
In order to limit the adverse effects of excessive inflammation, anti-inflammatory responses are stimulated at an early stage of an infection, but during sepsis these can lead to deactivation of immune cells including monocytes. In addition, there is
Externí odkaz:
https://doaj.org/article/e3d3a40efb8e4b5e9c5d241718315a08
Autor:
M, Annicchiarico-Petruzzelli, F, Bernassola, P E, Lovat, C P, Redfern, A D, Pearson, G, Melino
Publikováno v:
Medical and pediatric oncology. 36(1)
The CD95/CD95 ligand (CD95L) system is a key regulator of apoptosis. To evaluate a possible role of the CD95/CD95L system in human neuroblastoma (NB) cells, we investigated the constitutive and interferongamma (INFgamma)-induced expression of CD95 an
Publikováno v:
Medical and pediatric oncology. 36(1)
9-cis retinoic acid (RA) is more effective than all-trans RA at inducing neuroblastoma differentiation in vitro, and has distinct biological properties with respect to its ability to promote apoptosis in N-type neuroblastoma cells. The cellular effec
Autor:
P E, Lovat, M, Ranalli, F, Bernassola, M, Tilby, A J, Malcolm, A D, Pearson, M, Piacentini, G, Melino, C P, Redfern
Publikováno v:
Medical and pediatric oncology. 35(6)
The RARbeta/gamma-selective retinoids fenretinide and CD437 induce caspase-dependent apoptosis but generate free radicals independently of caspases. Apoptosis, but not free radical generation, induced by these retinoids is inhibited by RARbeta/gamma-
Autor:
P E, Lovat, M, Ranalli, F, Bernassola, M, Tilby, A J, Malcolm, A D, Pearson, M, Piacentini, G, Melino, C P, Redfern
Publikováno v:
International journal of cancer. 88(6)
Retinoic acid therapy improves the survival of children with neuroblastoma and 13-cis retinoic acid now forms an important component of treatment for residual disease of stage IV neuroblastoma after chemotherapy. However, although 13-cis retinoic aci
Publikováno v:
Journal of neuro-oncology. 31(1-2)
To date, the clinical success of 13-cis or all-trans retinoic acid in the treatment of neuroblastoma has been disappointing. In vivo, 13-cis will isomerise to both all-trans and 9-cis retinoic acid, believed to be the main biologically-active isomers
Autor:
Marco, Corazzari, E, Lovat Penny, Serafina, Oliverio, J, Pearson Andy D, Mauro, Piacentini, F, Redfern Christopher P
Publikováno v:
Molecular Pharmacology; December 2003, Vol. 64 Issue: 6 p1370-8, 9p
Publikováno v:
Advances in experimental medicine and biology. 186